Amphastar Pharmaceuticals, Inc.
AMPH
$22.74
-$0.19-0.83%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 290.12M | 291.95M | 282.81M | 276.21M | 231.75M |
| Total Receivables | 147.49M | 157.45M | 160.73M | 148.87M | 145.59M |
| Inventory | 179.91M | 170.19M | 176.89M | 185.93M | 191.73M |
| Prepaid Expenses | 11.00M | 11.65M | 13.15M | 26.02M | 9.33M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 2.44M | 2.44M | 2.44M | 2.44M | 2.44M |
| Total Current Assets | 630.95M | 633.68M | 636.02M | 639.47M | 580.83M |
|
|
|||||
| Total Current Assets | 630.95M | 633.68M | 636.02M | 639.47M | 580.83M |
| Net Property, Plant & Equipment | 389.13M | 378.91M | 353.72M | 353.53M | 354.73M |
| Long-term Investments | 3.31M | 3.33M | 3.40M | 3.40M | 3.40M |
| Goodwill | 3.31M | 3.33M | 3.40M | 3.40M | 3.40M |
| Total Other Intangibles | 644.52M | 556.29M | 562.56M | 568.83M | 575.10M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 75.86M | 75.94M | 73.60M | 100.99M | 99.22M |
| Total Assets | 1.74B | 1.65B | 1.63B | 1.67B | 1.62B |
|
|
|||||
| Total Accounts Payable | 28.93M | 35.50M | 32.59M | 40.54M | 41.88M |
| Total Accrued Expenses | 201.70M | 97.84M | 96.76M | 96.25M | 105.44M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 11.29M | 11.38M | 9.57M | 8.75M | 8.81M |
| Total Finance Division Other Current Liabilities | 21.29M | 19.77M | 19.24M | 59.69M | 20.28M |
| Total Other Current Liabilities | 21.29M | 19.77M | 19.24M | 59.69M | 20.28M |
| Total Current Liabilities | 263.21M | 164.48M | 158.16M | 205.23M | 176.41M |
|
|
|||||
| Total Current Liabilities | 263.21M | 164.48M | 158.16M | 205.23M | 176.41M |
| Long-Term Debt | 609.38M | 609.71M | 608.66M | 608.28M | 607.38M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 67.66M | 65.29M | 37.77M | 39.74M | 39.31M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 35.37M | 35.29M | 35.91M | 36.23M | 34.75M |
| Total Liabilities | 975.61M | 874.77M | 840.49M | 889.48M | 857.85M |
|
|
|||||
| Common Stock & APIC | 553.01M | 543.82M | 535.39M | 527.22M | 520.59M |
| Retained Earnings | 703.65M | 673.30M | 666.88M | 642.45M | 625.10M |
| Treasury Stock & Other | -488.50M | -443.73M | -413.46M | -392.93M | -388.21M |
| Total Common Equity | 768.16M | 773.39M | 788.81M | 776.75M | 757.48M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 768.16M | 773.39M | 788.81M | 776.75M | 757.48M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 768.16M | 773.39M | 788.81M | 776.75M | 757.48M |
|
|
|||||